Evidence map›Paper›PMID 40291004›Full record

ArticleACS omega2025

Profiling of the Peripheral Blood Mononuclear Cells Proteome by Shotgun Proteomics Identifies Alterations of Immune System Components, Proteolytic Balance, Autophagy, and Mitochondrial Metabolism in Glaucoma Subjects.

Sara Giammaria, Irene Pandino, Gabriele Antonio Zingale, Maria Grazia Atzori, Dario Cavaterra, Michela Cecere, Manuele Michelessi, Gloria Roberti, Lucia Tanga, Carmela Carnevale and 9 more

Abstract read
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sara GiammariaIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Irene PandinoIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Gabriele Antonio ZingaleIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Maria Grazia AtzoriIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Dario CavaterraDepartment of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, Rome 00133, Italy.
Michela CecereIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Manuele MichelessiIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Gloria RobertiIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Lucia TangaIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Carmela CarnevaleIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Alice Verticchio VercellinIcahn School of Medicine at Mount Sinai, New York 10029-6574, United States.
Brent SieskyIcahn School of Medicine at Mount Sinai, New York 10029-6574, United States.
Alon HarrisIcahn School of Medicine at Mount Sinai, New York 10029-6574, United States.
Giuseppe GrassoDepartment of Chemical SciencesUniversity of Catania, Viale Andrea Doria 6, Catania 95125, Italy.ORCID https://orcid.org/0000-0002-7179-4835
Alessio BocediDepartment of Chemical Sciences and Technologies, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, Rome 00133, Italy.
Massimiliano ColettaIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Grazia Raffaella TundoDepartment of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Via Montpellier 1, Roma 00133, Italy.
Francesco OddoneIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.
Diego SbardellaIRCCS Fondazione Bietti, Via Livenza, 3, Rome 00198, Italy.ORCID https://orcid.org/0000-0002-9924-7761

Funding

Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamicsR01EY030851 · NEI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ARCIERO, JULIA, HARRIS, ALON · 2020 to 2023
$1.3M
SCH: SEEthroughGLAUCOMA: Smart Eye Emulator (SEE) to study glaucoma risk factorsR01EY034718 · NEI · UNIVERSITY OF MAINE ORONO · PI GUIDOBONI, GIOVANNA, HARRIS, ALON · 2022 to 2025
$975k
NEI NIH HHS R01 EY030851NEI NIH HHS R01 EY034718
6 · The paper itself

Abstract

Glaucoma is a chronic optic neuropathy and is the second cause of irreversible blindness worldwide. Although the pathogenesis of the disease is not fully understood, the death of retinal ganglion cells and degeneration of the optic nerve are likely promoted by a combination of local and systemic factors. Growing attention has been paid to nonintraocular pressure risk factors, including mechanisms of inflammation and neuroinflammation. Phenotypical and molecular alterations of circulating immune cells, in particular, lymphocyte subsets, have been documented in murine models of glaucoma and in human subjects. Very recently, oxygen consumption rate and nicotinamide adenine dinucleotide levels of human peripheral blood mononuclear cells (PBMC) have been proposed as biomarkers of disease progression, thus suggesting that immune cells of glaucoma subjects present severe molecular and metabolic alterations. In this framework, this pilot study aimed to be the first to characterize global proteome perturbations of PBMC of patients with primary open-angle glaucoma (POAG) compared to nonglaucomatous controls (control) by shotgun proteomics. The approach identified >4,500 proteins and a total of 435 differentially expressed proteins between POAG and control subjects. Clustering and rationalization of proteomic data sets and immunodetection of selected proteins by Western blotting highlighted significant alterations of immune system compartments (i.e., complement factors, regulators of immune functions, and lymphocyte activation) and pathways serving key roles for immune system such as proteolysis (i.e., matrix metalloproteinases and their inhibitors), autophagy (i.e., beclin-1 and LC3B), cell proliferation (Bcl2), mitochondrial (i.e., sirtuin), and energetic/redox metabolism (i.e., NADK). Based on these findings, this proteomic study suggests that circulating immune cells suffer from heterogeneous alterations of central pathways involved in cell metabolism and homeostasis. Larger, properly designed studies are required to confirm specifically how immune cellular alterations may be involved in the pathogenesis of both neuroinflammation and glaucomatous disease.

Identifiers

PMID40291004
PMCPMC12019430

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.